drugset / Trial / NCT06695585
Optimal Intravesical Lidocaine Volume for Pain Relief During Office Intra-detrusor Onabotulinum Toxin a Injections
RandomizedParallel-groupQuadruple-blindSupportive care
Summary
The purpose of our study is to evaluate the efficacy and safety of different volumes of bladder-numbing medication for pain relief at the time of office bladder Botox injections. This is a randomized prospective, double-blind superiority trial comparing 200 ml 2% lidocaine versus 30 ml 2% lidocaine for office Botox injections.
Timeline
- Start
- 2024-12-01
- Primary completion
- 2025-06-01
- Completion
- 2025-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Lidocaine | Other / unclassified | 30 ml | Intrathecal |
| Comparator | Lidocaine | Other / unclassified | 200 ml | Intrathecal |